See also this year's filing and all EDGAR filings for this company.
PDF Report 0001678660_2021_Prelude_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001678660')"} |
Graph
Absolute values for 0001678660, Prelude Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 220,809,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,480,000 |
| 3 | remainder_Assets | 301,000 |
| 4 | LiabilitiesCurrent | 11,375,000 |
| 5 | LiabilitiesNoncurrent | 32,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,586,000 |
| 9 | ResearchAndDevelopmentExpense | 48,177,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,834,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 223,590,000 |
| 1 | Liabilities | 11,407,000 |
| 2 | Expenses | 58,763,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 212,183,000 |
| 5 | NetIncome | -56,929,000 |
| 6 | ComprehensiveNetIncome | -56,929,000 |
| 7 | BaseVar | 147,797,000 |
| 8 | EconomicCapitalRatio | 2.62 |
Edgar->Model Mapping
Feature Distribution
Change over Time
